Home/Filings/4/0000899243-22-007631
4//SEC Filing

Gaiero David G 4

Accession 0000899243-22-007631

CIK 0001662244other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:54 PM ET

Size

5.5 KB

Accession

0000899243-22-007631

Insider Transaction Report

Form 4
Period: 2022-02-22
Gaiero David G
Vice President, Finance
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-22+23,00023,000 total
    Exercise: $5.96Exp: 2032-02-22Common Stock (23,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments, subject to the Reporting Person's continued employment with the Company through the applicable vesting date.

Issuer

Cyteir Therapeutics, Inc.

CIK 0001662244

Entity typeother

Related Parties

1
  • filerCIK 0001799784

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:54 PM ET
Size
5.5 KB